Literature DB >> 22139700

The risks and benefits of transseptal endocardial pacing.

Zachary Whinnett1, Pierre Bordachar.   

Abstract

PURPOSE OF REVIEW: Transseptal endocardial left-ventricular pacing has a number of potential advantages over left-ventricular epicardial pacing from the coronary sinus, for implantation of cardiac resynchronization therapy (CRT) devices. In this study we review the risks and potential benefits. RECENT
FINDINGS: Permanent transseptal endocardial pacing has been shown to be clinically feasible. Different methods have been described, including a superior, inferior or mixed approach. Endocardial pacing has a number of potential advantages over conventional left-ventricular pacing from the coronary sinus. It may be possible to achieve more effective CRT through optimizing the left-ventricular lead position, which is possible because of the greater choice of stimulation site. Endocardial rather than epicardial stimulation may result in more rapid ventricular activation and may be less arrhythmogenic. Disadvantages of this approach include the risk of thromboembolism and the potential for interaction with the mitral valve.
SUMMARY: Transseptal endocardial left-ventricular pacing shows promise for use in cardiac resynchronization therapy. The safety and effectiveness of this technique should now be tested in larger clinical trials.

Entities:  

Mesh:

Year:  2012        PMID: 22139700     DOI: 10.1097/HCO.0b013e32834dc3d4

Source DB:  PubMed          Journal:  Curr Opin Cardiol        ISSN: 0268-4705            Impact factor:   2.161


  6 in total

Review 1.  Cardiac resynchronization therapy: Dire need for targeted left ventricular lead placement and optimal device programming.

Authors:  Sokratis Pastromas; Antonis S Manolis
Journal:  World J Cardiol       Date:  2014-12-26

Review 2.  Lead or be led: an update on leadless cardiac devices for general physicians.

Authors:  Benedict M Wiles; Paul R Roberts
Journal:  Clin Med (Lond)       Date:  2017-02       Impact factor: 2.659

Review 3.  Endocardial pacing: the wave of the future?

Authors:  Pierre Bordachar; Sylvain Ploux; Joost Lumens
Journal:  Curr Cardiol Rep       Date:  2012-10       Impact factor: 2.931

Review 4.  Leadless Cardiac Pacemakers: Pacing Paradigm Change.

Authors:  Petr Neuzil; Vivek Y Reddy
Journal:  Curr Cardiol Rep       Date:  2015-08       Impact factor: 2.931

5.  Vector selection of a quadripolar left ventricular pacing lead affects acute hemodynamic response to cardiac resynchronization therapy: a randomized cross-over trial.

Authors:  Stefan Asbach; Maximilian Hartmann; Tobias Wengenmayer; Erika Graf; Christoph Bode; Juergen Biermann
Journal:  PLoS One       Date:  2013-06-24       Impact factor: 3.240

Review 6.  Understanding non-response to cardiac resynchronisation therapy: common problems and potential solutions.

Authors:  Benjamin J Sieniewicz; Justin Gould; Bradley Porter; Baldeep S Sidhu; Thomas Teall; Jessica Webb; Gerarld Carr-White; Christopher A Rinaldi
Journal:  Heart Fail Rev       Date:  2019-01       Impact factor: 4.214

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.